These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 9180291
1. Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117. Haase D, Feuring-Buske M, Schäfer C, Schoch C, Troff C, Gahn B, Hiddemann W, Wörmann B. Leukemia; 1997 May; 11(5):674-9. PubMed ID: 9180291 [Abstract] [Full Text] [Related]
2. Involvement and functional impairment of the CD34(+)CD38(-)Thy-1(+) hematopoietic stem cell pool in myelodysplastic syndromes with trisomy 8. Nilsson L, Astrand-Grundström I, Anderson K, Arvidsson I, Hokland P, Bryder D, Kjeldsen L, Johansson B, Hellström-Lindberg E, Hast R, Jacobsen SE. Blood; 2002 Jul 01; 100(1):259-67. PubMed ID: 12070035 [Abstract] [Full Text] [Related]
3. Cytogenetically aberrant cells in the stem cell compartment (CD34+lin-) in acute myeloid leukemia. Mehrotra B, George TI, Kavanau K, Avet-Loiseau H, Moore D, Willman CL, Slovak ML, Atwater S, Head DR, Pallavicini MG. Blood; 1995 Aug 01; 86(3):1139-47. PubMed ID: 7542497 [Abstract] [Full Text] [Related]
13. LW/SO cell line: a tool for studying the phenotypical characterization and commitment of hematopoietic stem cells. Oez S, Trautmann U, Smetak M, Birkmann J, al salemeh S, Gebhart E, Gallmeier WM. Ann Hematol; 1996 May 27; 72(5):307-16. PubMed ID: 8645743 [Abstract] [Full Text] [Related]
14. Identification of campath-1 (CD52) as novel drug target in neoplastic stem cells in 5q-patients with MDS and AML. Blatt K, Herrmann H, Hoermann G, Willmann M, Cerny-Reiterer S, Sadovnik I, Herndlhofer S, Streubel B, Rabitsch W, Sperr WR, Mayerhofer M, Rülicke T, Valent P. Clin Cancer Res; 2014 Jul 01; 20(13):3589-602. PubMed ID: 24799522 [Abstract] [Full Text] [Related]
15. Expression of HOX genes, HOX cofactors, and MLL in phenotypically and functionally defined subpopulations of leukemic and normal human hematopoietic cells. Kawagoe H, Humphries RK, Blair A, Sutherland HJ, Hogge DE. Leukemia; 1999 May 01; 13(5):687-98. PubMed ID: 10374871 [Abstract] [Full Text] [Related]
16. Expression of CD90, CD96, CD117, and CD123 on different hematopoietic cell populations from pediatric patients with acute myeloid leukemia. Chávez-González A, Dorantes-Acosta E, Moreno-Lorenzana D, Alvarado-Moreno A, Arriaga-Pizano L, Mayani H. Arch Med Res; 2014 May 01; 45(4):343-50. PubMed ID: 24751333 [Abstract] [Full Text] [Related]
17. Deficiency of CD34+ c-kit+ and CD34+38- hematopoietic precursors in aplastic anemia after immunosuppressive treatment. Manz CY, Nissen C, Wodnar-Filipowicz A. Am J Hematol; 1996 Aug 01; 52(4):264-74. PubMed ID: 8701944 [Abstract] [Full Text] [Related]
19. CD45dimCD34+CD38-CD133+ cells have the potential as leukemic stem cells in acute myeloid leukemia. Heo SK, Noh EK, Ju LJ, Sung JY, Jeong YK, Cheon J, Koh SJ, Min YJ, Choi Y, Jo JC. BMC Cancer; 2020 Apr 06; 20(1):285. PubMed ID: 32252668 [Abstract] [Full Text] [Related]
20. Analysis of CD34-positive cells in bone marrow from patients with myelodysplastic syndromes and acute myeloid leukemia and in normal individuals: a comparison between FACS analysis and immunohistochemistry. Kanter-Lewensohn L, Hellström-Lindberg E, Kock Y, Elmhorn-Rosenborg A, Ost A. Eur J Haematol; 1996 Mar 06; 56(3):124-9. PubMed ID: 8598230 [Abstract] [Full Text] [Related] Page: [Next] [New Search]